Geoffrey A Targett

Summary

Affiliation: London School of Hygiene and Tropical Medicine
Country: UK

Publications

  1. pmc Malaria vaccine research and development: the role of the WHO MALVAC committee
    Geoffrey A T Targett
    Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT UK
    Malar J 12:362. 2013
  2. pmc Sympatric Plasmodium falciparum isolates from Venezuela have structured var gene repertoires
    Adriana Tami
    Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
    Malar J 2:7. 2003
  3. pmc Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy
    Wilfred F Mbacham
    Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon
    Malar J 9:34. 2010
  4. ncbi request reprint Vaccine efficacy, and immunity affecting transmission
    G Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
    Parassitologia 41:433-6. 1999
  5. ncbi request reprint Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae
    G Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
    J Infect Dis 183:1254-9. 2001
  6. ncbi request reprint Malaria vaccines 1985-2005: a full circle?
    Geoffrey A Targett
    Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London WC1B 3DP, UK
    Trends Parasitol 21:499-503. 2005
  7. pmc Malaria vaccines and their potential role in the elimination of malaria
    Geoffrey A Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 7:S10. 2008
  8. doi request reprint Do we still need a malaria vaccine?
    B Greenwood
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC 1E 7HT, UK
    Parasite Immunol 31:582-6. 2009
  9. ncbi request reprint Capacity strengthening in malaria research: the Gates Malaria Partnership
    Brian M Greenwood
    Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London, WC1B 3DP, UK
    Trends Parasitol 22:278-84. 2006

Collaborators

Detail Information

Publications9

  1. pmc Malaria vaccine research and development: the role of the WHO MALVAC committee
    Geoffrey A T Targett
    Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT UK
    Malar J 12:362. 2013
    ..These informed discussions and opinions are summarized here to provide guidance on harmonization of strategies to help ensure high standards of practice and comparability between centres and the outcome of vaccine trials. ..
  2. pmc Sympatric Plasmodium falciparum isolates from Venezuela have structured var gene repertoires
    Adriana Tami
    Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
    Malar J 2:7. 2003
    ..Studies to date have compared var repertoires of natural isolates from various geographical locations but have not addressed any within-population structure that may exist among repertoires...
  3. pmc Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy
    Wilfred F Mbacham
    Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon
    Malar J 9:34. 2010
    ..The prevalence of molecular markers for resistance to these drugs was studied to set the baseline for surveillance of their evolution with time...
  4. ncbi request reprint Vaccine efficacy, and immunity affecting transmission
    G Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
    Parassitologia 41:433-6. 1999
    ....
  5. ncbi request reprint Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae
    G Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
    J Infect Dis 183:1254-9. 2001
    ..Artesunate reduced posttreatment infectivity dramatically but did not abolish it completely. The study raises questions about any policy to use pyrimethamine-sulfadoxine alone as the first-line treatment for malaria...
  6. ncbi request reprint Malaria vaccines 1985-2005: a full circle?
    Geoffrey A Targett
    Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London WC1B 3DP, UK
    Trends Parasitol 21:499-503. 2005
    ..Why is it still proving so challenging to produce effective vaccines?..
  7. pmc Malaria vaccines and their potential role in the elimination of malaria
    Geoffrey A Targett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 7:S10. 2008
    ..This might be achieved with some pre-erythrocytic stage candidate vaccines or by targeting the sexual stages directly with transmission-blocking vaccines. An expanded malaria vaccine programme with such objectives is now a priority...
  8. doi request reprint Do we still need a malaria vaccine?
    B Greenwood
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC 1E 7HT, UK
    Parasite Immunol 31:582-6. 2009
    ..Malaria vaccines with transmission-blocking properties could play a key role in future elimination programmes...
  9. ncbi request reprint Capacity strengthening in malaria research: the Gates Malaria Partnership
    Brian M Greenwood
    Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London, WC1B 3DP, UK
    Trends Parasitol 22:278-84. 2006
    ..Capacity development, notably through a PhD programme, has been an underlying feature of all aspects of the programme...